- Home
- SPRY vs PGRE Comparison
SPRY vs PGRE Comparison
Compare SPRY & PGRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- PGRE
- Stock Information
- Founded
- SPRY 2015
- PGRE 1978
- Country
- SPRY United States
- PGRE United States
- Employees
- SPRY 24
- PGRE N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- PGRE Real Estate Investment Trusts
- Sector
- SPRY Health Care
- PGRE Real Estate
- Exchange
- SPRY Nasdaq
- PGRE Nasdaq
- Market Cap
- SPRY 1.2B
- PGRE 991.9M
- IPO Year
- SPRY N/A
- PGRE 2014
- Fundamental
- Price
- SPRY $11.95
- PGRE $4.02
- Analyst Decision
- SPRY Strong Buy
- PGRE Hold
- Analyst Count
- SPRY 5
- PGRE 4
- Target Price
- SPRY $26.80
- PGRE $4.63
- AVG Volume (30 Days)
- SPRY 1.3M
- PGRE 1.0M
- Earning Date
- SPRY 03-20-2025
- PGRE 04-30-2025
- Dividend Yield
- SPRY N/A
- PGRE 1.75%
- EPS Growth
- SPRY N/A
- PGRE N/A
- EPS
- SPRY N/A
- PGRE N/A
- Revenue
- SPRY $2,568,000.00
- PGRE $710,365,000.00
- Revenue This Year
- SPRY $61,233.33
- PGRE N/A
- Revenue Next Year
- SPRY $585.54
- PGRE N/A
- P/E Ratio
- SPRY N/A
- PGRE N/A
- Revenue Growth
- SPRY 8460.00
- PGRE 50.61
- 52 Week Low
- SPRY $7.55
- PGRE $3.97
- 52 Week High
- SPRY $18.51
- PGRE $5.47
- Technical
- Relative Strength Index (RSI)
- SPRY 55.76
- PGRE 28.66
- Support Level
- SPRY $10.00
- PGRE $3.97
- Resistance Level
- SPRY $11.55
- PGRE $4.34
- Average True Range (ATR)
- SPRY 0.69
- PGRE 0.16
- MACD
- SPRY 0.21
- PGRE -0.04
- Stochastic Oscillator
- SPRY 78.00
- PGRE 14.12
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About PGRE Paramount Group Inc.
Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. Paramount Group derives nearly all of its revenue in the form of rental income from leasing its offices to tenants.